Speciallægerne Centrum Reumatologerne ApS: Financial statements 2017
CVR: 36945966
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Speciallægerne Centrum Reumatologerne ApS (CVR 36945966) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,626,712 and a net result of DKK 401,210. Equity in the 2017 report amounted to DKK 820,925. The solvency ratio was 70.5%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,626,712
- Profit/Loss
- DKK 401,210
- Equity
- DKK 820,925
- Total Assets
- DKK 1,164,010
- Employees
- 3
Official annual report
Keep an eye on Speciallægerne Centrum Reumatologerne ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of November 3, 2017, REVISIONSFIRMAET WOIREMOSE & PARTNER REGISTRERET REVISIONSANPARTSSELSKAB has stepped down as auditor of Speciallægerne Centrum Reumatologerne ApS.
Speciallægerne Centrum Reumatologerne ApS has published its interim report for the period July 1, 2015 to December 31, 2016.
About Speciallægerne Centrum Reumatologerne ApS
Speciallægerne Centrum Reumatologerne ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2015. The company is registered under the industry Speciallægers aktiviteter. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 3,001,482 and a net result of DKK 562,624 compared with DKK 341,485 the year before. Equity in the 2025 report amounted to DKK 615,795.
